Mark Bower
Impact in
- Oncology top 0.2%
- Viral-associated cancers and disorders
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
- Oncology 182
- Viral-associated cancers and disorders 154
- COVID-19 and healthcare impacts 13
- Cancer Immunotherapy and Biomarkers 8
-
- HIV/AIDS drug development and treatment 21
- Co-authors
- Mark Richard Nelson (105 shared papers)Brian Gazzard (98 shared papers)Justin Stebbing (110 shared papers)Sundhiya Mandalia (33 shared papers)Edward S. Newlands (25 shared papers)Tom Powles (19 shared papers)Gordon J.S. Rustin (16 shared papers)Thomas B. Powles (22 shared papers)
- Journals
- AIDS (36 papers)Journal of Clinical Oncology (22 papers)Blood (20 papers)European Journal of Cancer (16 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (15 papers)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Mark Bower
405 papers receiving 15.1k citations
Mark Bower's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 5.5k
- Infectious Diseases 1.0k
- Genetics 451
- Virology 238
- Hepatology 299
Countries citing papers authored by Mark Bower
This map shows the geographic impact of Mark Bower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bower more than expected).
Fields of papers citing papers by Mark Bower
This network shows the impact of papers produced by Mark Bower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bower. The network helps show where Mark Bower may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Bower, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 419 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer Hit paper breakdown → | 2019 | 502 |
| 2 | Kaposi sarcoma Hit paper breakdown → | 2019 | 475 |
| 3 | A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias Hit paper breakdown → | 1992 | 424 |
| 4 | 2005 | 321 | |
| 5 | 2008 | 294 | |
| 6 | 2017 | 267 | |
| 7 | 1997 | 248 | |
| 8 | Phase I trial of temozolomide using an extended continuous oral schedule. | 1998 | 242 |
| 9 | 2005 | 206 | |
| 10 | 1997 | 200 | |
| 11 | 2001 | 195 | |
| 12 | 2012 | 195 | |
| 13 | 2008 | 192 | |
| 14 | 2010 | 181 | |
| 15 | 2000 | 173 | |
| 16 | 2013 | 170 | |
| 17 | 2004 | 167 | |
| 18 | 2007 | 157 | |
| 19 | 2020 | 153 | |
| 20 | 2004 | 148 |
About Mark Bower
Mark Bower is a scholar working on Oncology, Infectious Diseases, Surgery, Public Health, Environmental and Occupational Health and Virology, having authored 419 papers that have together received 15.8k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (154 papers), HIV/AIDS drug development and treatment (21 papers), Colorectal and Anal Carcinomas (14 papers), Testicular diseases and treatments (13 papers), COVID-19 and healthcare impacts (13 papers), Gestational Trophoblastic Disease Studies (13 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Glioma Diagnosis and Treatment (7 papers). The work is most often cited by research in Oncology (5.5k citations), Infectious Diseases (1.0k citations), Genetics (451 citations), Virology (238 citations) and Hepatology (299 citations). Mark Bower has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Mark Richard Nelson, Brian Gazzard, Justin Stebbing, Sundhiya Mandalia, Edward S. Newlands, Tom Powles, Gordon J.S. Rustin, Thomas B. Powles, Tom Newsom‐Davis and David James Pinato. Their work appears in journals such as AIDS, Journal of Clinical Oncology, Blood, European Journal of Cancer and JAIDS Journal of Acquired Immune Deficiency Syndromes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.